BNP Paribas Financial Markets’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q2 | – | Sell |
-31
| Closed | -$1.66K | – | 3650 |
|
2016
Q1 | $1.66K | Sell |
31
-8,077
| -100% | -$432K | ﹤0.01% | 2441 |
|
2015
Q4 | $916K | Sell |
8,108
-2,691
| -25% | -$304K | ﹤0.01% | 1136 |
|
2015
Q3 | $1.27M | Buy |
10,799
+4,390
| +68% | +$517K | ﹤0.01% | 975 |
|
2015
Q2 | $496K | Buy |
6,409
+2,623
| +69% | +$203K | ﹤0.01% | 1345 |
|
2015
Q1 | $219K | Sell |
3,786
-8,214
| -68% | -$475K | ﹤0.01% | 1539 |
|
2014
Q4 | $387K | Sell |
12,000
-5,333
| -31% | -$172K | ﹤0.01% | 1199 |
|
2014
Q3 | $424K | Buy |
17,333
+1,125
| +7% | +$27.5K | ﹤0.01% | 1368 |
|
2014
Q2 | $287K | Buy |
16,208
+4,208
| +35% | +$74.6K | ﹤0.01% | 1430 |
|
2014
Q1 | $198K | Buy |
12,000
+11,672
| +3,559% | +$192K | ﹤0.01% | 1555 |
|
2013
Q4 | $5.5K | Buy |
+328
| New | +$5.5K | ﹤0.01% | 2553 |
|
2013
Q3 | – | Sell |
-11,244
| Closed | -$62.9K | – | 2524 |
|
2013
Q2 | $62.9K | Buy |
+11,244
| New | +$62.9K | ﹤0.01% | 2304 |
|